Literature DB >> 7872755

Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of human polymorphonuclear leukocytes.

T Vago1, G Baldi, D Colombo, M Barbareschi, G Norbiato, F Dallegri, M Bevilacqua.   

Abstract

Many antimycotic agents negatively affect the natural immune response. Typically, these drugs impair polymorphonuclear leukocyte (PMN) production of superoxide anion, chemotaxis, or the killing of pathogens. Allylamines are a new class of antimycotic compounds with a new mechanism of antifungal action, i.e., inhibition of the fungal squalene epoxidase. The trial that we describe aimed to evaluate the effects of two allylamines, terbinafine and naftifine, on selected functions of PMNs, i.e., superoxide anion production, chemotaxis, and killing of Candida albicans blastospores. Terbinafine and naftifine on their own did not affect superoxide anion production when they were added to PMNs. When PMNs were preincubated with allylamines and were then stimulated by N-formyl-Met-Leu-Phe or phorbol 12-myristate 13-acetate, superoxide anion production was increased (priming effect). Since intracellular free calcium (Ca2+i) is involved in the control of superoxide anion production, we evaluated the effects of the allylamines on the Ca2+i concentration ([Ca2+]i). In the presence of terbinafine or naftifine, the [Ca2+]i increased in a dose-dependent manner; the source of Ca2+i was not extracellular since it was not affected by extracellular calcium chelation with ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid. In the presence of terbinafine or naftifine, chemotaxis of PMNs was not impaired. Terbinafine and naftifine slightly but significantly increased the killing of C. albicans blastospores (P < 0.05 at 10 and 100 microM). In conclusion, in contrast to imidazole-like drugs, the allylamine antimycotic compounds terbinafine and naftifine enhance selected functions of PMNs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7872755      PMCID: PMC188249          DOI: 10.1128/AAC.38.11.2605

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  61 in total

1.  Enhancement of macrophage superoxide anion production by amphotericin B.

Authors:  E Wilson; L Thorson; D P Speert
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

Review 2.  Allylamine antifungal drugs.

Authors:  N S Ryder; H Mieth
Journal:  Curr Top Med Mycol       Date:  1992

3.  Lipid complexing decreases amphotericin B inflammatory activation of human neutrophils compared with that of a desoxycholate-suspended preparation of amphotericin B (Fungizone).

Authors:  G W Sullivan; H T Carper; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

4.  Synergistic action of amphotericin B and rifampin on Candida albicans.

Authors:  W H Beggs; G A Sarosi; F A Andrews
Journal:  Am Rev Respir Dis       Date:  1974-11

5.  Activity of amphotericin B and intraconazole against intraphagocytic Candida albicans.

Authors:  E Ponce; J C Pechère
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

6.  Suppression of neutrophil and lymphoproliferative responses in vitro by itraconazole but not fluconazole.

Authors:  V Vuddhakul; G T Mai; J G McCormack; W K Seow; Y H Thong
Journal:  Int J Immunopharmacol       Date:  1990

7.  Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.

Authors:  J W Van 't Wout; I Meynaar; I Linde; R Poell; H Mattie; R Van Furth
Journal:  J Antimicrob Chemother       Date:  1990-05       Impact factor: 5.790

8.  Bacterial lipopolysaccharide enhances polymorphonuclear leukocyte function independent of changes in intracellular calcium.

Authors:  J B Klein; V Payne; T M Schepers; K R McLeish
Journal:  Inflammation       Date:  1990-10       Impact factor: 4.092

9.  Priming and stimulation of bovine neutrophils by recombinant human interleukin-1 alpha and tumor necrosis factor alpha.

Authors:  A K Sample; C J Czuprynski
Journal:  J Leukoc Biol       Date:  1991-02       Impact factor: 4.962

10.  Disparate effects of interferon-gamma and tumor necrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro.

Authors:  R D Diamond; C A Lyman; D R Wysong
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

View more
  4 in total

Review 1.  Antifungal agents: chemotherapeutic targets and immunologic strategies.

Authors:  N H Georgopapadakou; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

2.  Comprehensive kinetic and modeling analyses revealed CYP2C9 and 3A4 determine terbinafine metabolic clearance and bioactivation.

Authors:  Dustyn A Barnette; Mary A Davis; Noah Flynn; Anirudh S Pidugu; S Joshua Swamidass; Grover P Miller
Journal:  Biochem Pharmacol       Date:  2019-10-09       Impact factor: 5.858

3.  [Generation of reactive oxygen species in vitro by Malassezia yeasts].

Authors:  S Später; U-C Hipler; U-F Haustein; P Nenoff
Journal:  Hautarzt       Date:  2009-02       Impact factor: 0.751

4.  Dehydrosqualene Desaturase as a Novel Target for Anti-Virulence Therapy against Staphylococcus aureus.

Authors:  Peng Gao; Julian Davies; Richard Yi Tsun Kao
Journal:  mBio       Date:  2017-09-05       Impact factor: 7.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.